Author
Listed:
- Mathieu Oosterlaken
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Angelina Rogliardo
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM
Institut des Neurosciences de Montpellier)
- Tatiana Lipina
(University of Toronto)
- Pierre-André Lafon
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Mireille Elodie Tsitokana
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Mathilde Keck
(CEA)
- Héloïse Cahuzac
(CEA)
- Pierre Prieu-Sérandon
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Séverine Diem
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Cécile Derieux
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Célia Camberlin
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Chrystel Lafont
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Damien Meyer
(Institute Paoli-Calmettes, CRCM, Aix Marseille University, CNRS, INSERM)
- Patrick Chames
(Institute Paoli-Calmettes, CRCM, Aix Marseille University, CNRS, INSERM)
- Franck Vandermoere
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM
Institute Paoli-Calmettes, CRCM, Aix Marseille University, CNRS, INSERM)
- Philippe Marin
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Laurent Prézeau
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Denis Servent
(CEA)
- Ali Salahpour
(University of Toronto)
- Amy J. Ramsey
(University of Toronto)
- Carine Bécamel
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Jean-Philippe Pin
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
- Julie Kniazeff
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM
Institut des Biomolécules Max Mousseron, Université de Montpellier, CNRS, ENSCM)
- Philippe Rondard
(Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM)
Abstract
There is an urgent need for efficient and innovative therapies to treat brain disorders such as psychiatric and neurodegenerative diseases. Immunotherapies have proved to be efficient in many medical areas, but have not been considered to treat brain diseases due to the poor brain penetration of immunoglobulins1,2. Here we developed a bivalent biparatopic antibody, made of two camelid heavy-chain antibodies (called nanobodies)3, one binding to, and the other potentiating the activity of, homodimeric metabotropic glutamate receptor 2. We show that this bivalent nanobody, given peripherally, reaches the brain and corrects cognitive deficits in two preclinical mouse models with endophenotypes resulting from NMDA receptor hypofunction. Notably, these in vivo effects last for at least 7 days after a single intraperitoneal injection and are maintained after subchronic treatment. Our results establish a proof of concept that nanobodies can target brain receptors, and pave the way for nanobody-based therapeutic strategies for the treatment of brain disorders.
Suggested Citation
Mathieu Oosterlaken & Angelina Rogliardo & Tatiana Lipina & Pierre-André Lafon & Mireille Elodie Tsitokana & Mathilde Keck & Héloïse Cahuzac & Pierre Prieu-Sérandon & Séverine Diem & Cécile Derieux & , 2025.
"Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction,"
Nature, Nature, vol. 645(8079), pages 262-270, September.
Handle:
RePEc:nat:nature:v:645:y:2025:i:8079:d:10.1038_s41586-025-09265-8
DOI: 10.1038/s41586-025-09265-8
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:645:y:2025:i:8079:d:10.1038_s41586-025-09265-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.